[1] Watson MA, Fleming TP. Mammaglobin,a mammary-specific member of the uteroglobin gene family is overexpressed in human breast cancer[J].Cancer Res, 1996, 56(4):860-865. [2] Becker RM, Darrow C, Zimonjie DB, et al. Identification of mammaglobin B,a novel member of the uteroglobin gene family[J]. Genomics, 1998, 54(1):70-78. [3] Oloomi M, Moazzezy N, Bouzari S. Modulation of molecular biomarker expression in response to chemotherapy in invasive ductal carcinoma[J]. Biomed Res Int, 2018,2018:7154708. [4] Li C, Zhang T. Human mammaglobin:A specific marker for breast cancer prognosis[J]. J Buon, 2016, 21(1):35-41. [5] Lv X, Feng X, Hao X, et al. Anti-hMAM monoclonal antibodies evaluated in breast and non-breast tissues for differential diagnosis implication[J]. Tumori, 2016, 2016(3):264-269. [6] 武帅,王斌,刘赟.人乳腺珠蛋白在乳腺癌组织中的表达及意义[J].中国药物与临床,2017,17(9):1299-1300. [7] 刘震,马德寿,沈国双.hMAM在乳腺癌前哨淋巴结中的表达及其临床意义分析[J].现代免疫学,2017,37(5):395-398. [8] 鲍慧铮,陈力,李思莹,等.CK19联合hMAM检测乳腺癌循环肿瘤细胞的临床价值[J].肿瘤,2014,34(2):153-157. [9] 于秀艳,张晓伟,野丽莉,等.hMAM联合MMP-9和C-erbB2 mRNA表达检测在乳腺癌外周血微转移诊断中的应用[J].吉林大学学报:医学版,2017,43(5):1009-1014. [10] Zucker S, Hymowitz M,Rollo EE, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer[J]. Am J Pathol, 2001, 158(6):1921-1928. [11] 冀峰,吕复君,李延翠.hMAM mRNA表达情况与乳腺癌的关系[J].癌症进展,2018, 16(3):315-317. [12] 印滇,王亚非,杨莉,等.hMAM水平与乳腺癌早期诊断和癌微转移的相关性及临床意义研究[J].临床和实验医学杂志,2015,14(18):1512-1515. [13] Al Joudi FS. Human mammaglobin in breast cancer:a brief review of its clinical utility[J]. Indian J Med Res, 2014, 139(5):675-685. [14] Goedegebuure PS, Watson MA, Viehl CT, et al. Mammaglobin-based strategies for treatment of breast cancer[J]. Curr Cancer Drug Targets, 2004, 4(6):531-542. [15] Strati A, Markou A, Parisi C, et al. Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR[J]. BMC Cancer,2011, 11(1):422. [16] Zhao S, Yang H, Zhang M, et al. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients[J]. Cell Biochem Biophys, 2013, 65(2):263-273. [17] Liu Y, Ma L, Liu X, et al. Expression of human mammaglobin as a marker of bone marrow micrometastasis in breast cancer[J]. Exp Ther Med, 2012, 3(3):550-554. [18] Yang J, Wang R, Li H, et al. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells[J]. Cancer Biomark, 2016, 17(2):237-247. [19] 赵超悦,宋润敏,秦晖,等.EMMPRIN糖基化突变质粒的构建及功能检测[J].吉林大学学报:医学版,2014,40(3):583-587. [20] Dimas DT, Perlepe CD, Sergentanis TN, et al. The prognostic significance of Hsp70/Hsp90 expression in breast cancer:A systematic review and meta-analysis[J]. Anticancer Res, 2018, 38(3):1551-1562. [21] Luz M, Perez M, Azzalis L, et al. Evaluation of MCT1, MCT4 and CD147 genes in peripheral blood cells of breast cancer patients and their potential use as diagnostic and prognostic markers[J]. Int J Mol Sci, 2017, 18(4):170-180. [22] 田英,姜专基,张志艳.乳腺癌患者血清hMAM检测的临床意义研究[J].国际检验医学杂志,2013,34(3):302-304. [23] 杨超,康炜,李建华,等.血清乳腺珠蛋白与乳腺癌的相关性及临床意义探讨[J].检验医学,2014,29(1):61-64. [24] Xue S, Li SX, Wu ZS, et al. Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer[J]. Chin J Path, 2009, 38(8):524-528. |